Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Tektonidou

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|February 11, 2017
Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseasesSophie Mavrogeni, George Markousis-Mavrogenis, Loukia Koutsogeorgopoulou, et al.
Clinical and Experimental Rheumatology|March 11, 2017
Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription databasePetros P Sfikakis, Vasiliki-Kalliopi Bournia, Prodromos Sidiropoulos, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 24, 2011
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis TrialMaria S Stoenoiu, Selda Aydin, Maria Tektonidou, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
The Israel Medical Association Journal : IMAJ|April 30, 2019
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through SynergyLazaros I Sakkas, Dimitrios P Bogdanos, Dimitrios Boumpas, et al.
Arthritis Care & Research|November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate CriteriaMedha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
Therapeutic Advances in Musculoskeletal Disease|October 16, 2020
Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patientsKonstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|February 11, 2017
Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseasesSophie Mavrogeni, George Markousis-Mavrogenis, Loukia Koutsogeorgopoulou, et al.
Clinical and Experimental Rheumatology|March 11, 2017
Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription databasePetros P Sfikakis, Vasiliki-Kalliopi Bournia, Prodromos Sidiropoulos, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 24, 2011
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis TrialMaria S Stoenoiu, Selda Aydin, Maria Tektonidou, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
The Israel Medical Association Journal : IMAJ|April 30, 2019
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through SynergyLazaros I Sakkas, Dimitrios P Bogdanos, Dimitrios Boumpas, et al.
Arthritis Care & Research|November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate CriteriaMedha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
Therapeutic Advances in Musculoskeletal Disease|October 16, 2020
Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patientsKonstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Pageof 6